NCT05233618 2025-05-28Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)University of VirginiaPhase 1 Recruiting44 enrolled
NCT02268253 2025-01-06Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)Stemline Therapeutics, Inc.Phase 1/2 Completed82 enrolled 15 charts